Assert-IQ vs Study Watch with Irregular Pulse Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

Study Watch with Irregular Pulse Monitor

by Verily Life Sciences

AI Verdict

Assert-IQ is an insertable cardiac monitor providing long-term, continuous monitoring for comprehensive arrhythmia detection, ideal for patients requiring extended diagnostic periods. In contrast, the Verily Study Watch is a prescription-only wearable for single-channel ECG recording and irregular pulse detection, primarily suited for clinical research and shorter-term monitoring in professional healthcare settings. While both address cardiac rhythm, their form factor, duration of monitoring, and primary use cases differentiate their direct comparability.

Choose Assert-IQ if…

Choose Assert-IQ if your healthcare system requires a long-term, highly reliable, and minimally invasive solution for continuous cardiac monitoring and advanced arrhythmia detection, especially for patients with infrequent or suspected heart rhythm disorders requiring extended diagnostic periods. This tool is ideal for large health systems and cardiology clinics seeking comprehensive remote monitoring capabilities and proactive clinician alerts for efficient patient management.

View Assert-IQ →

Choose Study Watch with Irregular Pulse Monitor if…

Choose Study Watch with Irregular Pulse Monitor if your focus is on clinical research or professional healthcare settings requiring a prescription-only wearable device for adult patients to monitor single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation. This tool is best suited for studies or practices that benefit from continuous data capture, an easy-to-use interface, and the ability to recommend ECG acquisition upon irregular pulse detection.

View Study Watch with Irregular Pulse Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Study Watch with Irregular Pulse Monitor
Pricing	Unknown	Contact for pricing
Deployment	Subcutaneously implanted device with mobile app connectivity	Device-based (wrist-worn watch)
FDA Status	Cleared AI-estimated	True AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Study Watch with Irregular Pulse Monitor

Tool B, the Verily Study Watch, is a wrist-worn device, generally considered less invasive and more comfortable for patients than an insertable cardiac monitor like Tool A. While both aim for continuous monitoring, the Study Watch's form factor likely leads to higher patient adherence and ease of use in daily life.

Clinical Value

Assert-IQ

Tool A, Assert-IQ, offers long-term continuous cardiac monitoring for up to 6 years and advanced AI algorithms that significantly reduce false positives while maintaining high sensitivity for AF and pause episodes. This provides more accurate and actionable data for physicians in diagnosing and managing complex arrhythmias.

Pricing & Value

Tie

Both tools require contacting the company for pricing details, indicating a lack of public transparency. Without specific pricing information or detailed cost-benefit analyses for each, it's impossible to definitively determine which offers better value. Both are enterprise-focused, suggesting complex pricing structures.

Enterprise Readiness

Assert-IQ

Tool A, Assert-IQ, is explicitly targeted at 'Large health systems, hospitals, cardiology clinics' and offers a secure cloud-based data platform, remote monitoring capabilities, and proactive clinician alerts. Its hybrid deployment and data export features further support integration into existing enterprise workflows.

Innovation

Assert-IQ

Tool A, Assert-IQ, stands out with its advanced AI algorithms specifically designed to reduce false positives in arrhythmia detection and its industry-leading battery life of up to 6 years for an insertable cardiac monitor. This combination of AI-powered accuracy and extended monitoring duration represents a significant innovation in the ICM space.

Support & Docs

Tie

Both companies are established in the healthcare sector, implying a certain level of support and documentation. However, specific details regarding the breadth, accessibility, or quality of their support and documentation are not provided in the given information or readily available through general web searches for either product, leading to a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Study Watch with Irregular Pulse Monitor
Product Name	Assert-IQ	Study Watch with Irregular Pulse Monitor
Company	Abbott Medical	Verily Life Sciences
Description	The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	The Verily Study Watch with Irregular Pulse Monitor is an FDA-cleared, prescription-only wearable device from Verily Life Sciences. It is designed for adult patients (22+) to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation, primarily for use in clinical research and professional healthcare settings.
Key Features	Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion	Single-channel ECG recording, storage, transfer, and display, Irregular pulse monitoring and notification (e.g., for Atrial Fibrillation), Recommendation for ECG acquisition upon irregular pulse detection, Built-in biometric, environmental, and movement sensors, Continuous data capture with long battery life (e.g., 3-day for related Numetric Watch), Designed for clinical research and investigational use, Easy-to-use interface and configurable firmware, Supports multiple languages
Target Size	Large health systems, hospitals, cardiology clinics	Not specified

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Study Watch with Irregular Pulse Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Assert-IQ is designed to streamline clinic workflow with features like remote programming, allowing clinicians to adjust device settings without in-person patient visits. Data from Assert-IQ is transmitted via Bluetooth to the Merlin.net Patient Care Network, which aims to reduce data burden by presenting curated, decision-ready views of arrhythmia classifications. Verily Study Watch is intended for use in clinical research and professional healthcare settings, with an aim to integrate mobile health data into the clinical care environment and support the physician-patient relationship. Verily is also working on integrating wearable data into its precision health platform, Pre, to accelerate research and provide advanced health analytics.

What is the accuracy and sensitivity of each tool for detecting cardiac arrhythmias, particularly atrial fibrillation?

Assert-IQ ICM utilizes advanced AI algorithms that have shown high accuracy in arrhythmia detection. It has demonstrated 100% patient sensitivity and 99.4% episode-based sensitivity for AF detection, while reducing false positives for AF by 81% and for Pause episodes by 91%. The Verily Study Watch with Irregular Pulse Monitor has shown high accuracy in identifying atrial fibrillation, with a per-interval sensitivity of 96.1% and specificity of 98.1% for AF detection when compared to a 14-day continuous ECG monitor.

Which specialties are these tools best suited for, and what clinical context should guide my choice?

Assert-IQ is primarily designed for cardiology and internal medicine, offering long-term continuous cardiac monitoring for comprehensive arrhythmia detection, including AF, bradycardia, tachycardia, and sinus pauses. It's particularly useful for diagnosing unexplained symptoms like dizziness, palpitations, and syncope, and for long-term management of patients undergoing therapy or at risk of developing further arrhythmias. The Verily Study Watch is indicated for adult patients (22+) with diagnosed or suspected atrial fibrillation, and is suitable for cardiology, family medicine, and internal medicine, especially in clinical research and professional healthcare settings where continuous single-channel ECG recording and irregular pulse monitoring are needed.

What is the typical learning curve for physicians and their staff, and what kind of support is provided?

Assert-IQ aims to improve clinical efficiency and reduce data fatigue through its AI-powered classification and curated data views. Abbott provides SyncUP Remote Monitoring Support experts to assist patients with setting up the myMerlin Mobile App and ensure timely data transmission, which can streamline outpatient implant workflows. While specific learning curve details for the Verily Study Watch are not explicitly stated, its easy-to-use interface and configurable firmware suggest an effort to minimize complexity. Verily's focus on integrating data into clinical care environments implies support for healthcare professionals in utilizing the device's data.

How do these tools support multi-site rollouts and customer reference availability?

Assert-IQ is designed for large health systems, hospitals, and cardiology clinics, suggesting suitability for multi-site rollouts. Abbott also provides weekly compliance reports on remote patient monitoring for enrolled clinics, which can aid in managing multi-site deployments. The Verily Study Watch has been deployed in studies across various locations, including the U.S., the Netherlands, and Japan, indicating its capability for multi-site research. Verily also collaborates with various partners and has been used in numerous clinical research studies.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Assert-IQ or Study Watch with Irregular Pulse Monitor

Backers

Who funded each tool's parent company.